Top Markets
Coin of the day
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

VTGN
Rang în acțiuni #31934
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity... VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and commercializing innovative medications for anxiety, depression, and various other disorders impacting the central nervous system (CNS). A key component of its CNS pipeline is PH94B, a fast-acting neuroactive nasal spray currently in Phase III trials for the rapid treatment of anxiety in adults experiencing social anxiety disorder. PH94B also shows potential for addressing a broader spectrum of anxiety conditions, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder (PTSD), pre-procedural anxiety, and panic disorders. The company's CNS development initiatives further encompass PH10, another quick-acting neuroactive nasal spray, which is in preparation for Phase 2B clinical assessment as a standalone therapy for major depressive disorder (MDD). Additionally, VistaGen is developing AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is being investigated in conjunction with oral probenecid for its potential application in treating levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. VistaGen has established various collaborations, including a contract research and development agreement with Cato Research Ltd., a licensing agreement with Pherin Pharmaceuticals, Inc., and a license and collaboration agreement with EverInsight Therapeutics Inc. Founded in 1998, VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
Preț acțiune
$0.2619
Ultima sincronizare: 2026-08-17
Capitalizare de piață
$11.62M
Schimbare (1 zi)
-2.13%
Schimbare (1 an)
-92.30%
Țară
US
Tranzacționează VistaGen Therapeutics, Inc. (VTGN)

Categorie

Prețul VTGN cu capitalizarea de piață a B
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.
VTGN
$0.2619
Capitalizarea de piață a VistaGen Therapeutics, Inc.(VTGN)
Capitalizare de piață: $11.62M
În anul August 2026, VistaGen Therapeutics, Inc. are o capitalizare de piață de $11.62M. Acest lucru face ca VistaGen Therapeutics, Inc. să fie a 31934th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a VistaGen Therapeutics, Inc. din 2011 până în 2026
VTGN în comparație cu top 5 cele mai populare stocks
Prețul pentru VTGN Activul B Capitalizarea de piață a B Rezultate
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.
$123,040 $11.62M
$5.460T +46,979,716.61%
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.
$101,167 $11.62M
$4.489T +38,628,057.12%
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.
$93,311.87 $11.62M
$4.141T +35,628,715.01%
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.
$80,414.22 $11.62M
$3.569T +30,704,070.07%
VistaGen Therapeutics, Inc. VistaGen Therapeutics, Inc.
$63,051.48 $11.62M
$2.798T +24,074,540.22%